Local Regulatory Partner for EU & US
Facilitating Safe and Effective Pharmaceuticals through Local Regulatory Collaboration
In the pharmaceutical sector,local health authorities generally collaborate with pharmaceutical companies to supervise and approve medications and medical equipment for efficacy and safety. This process involves examining clinical trial data, monitoring post-approval safety, and inspecting manufacturing facilities. Several important health agencies include the European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA), and the US Food and Drug Administration (FDA). These organisations are essential in maintaining public health because they establish guidelines and implement rules pertaining to the creation and dispensing of pharmaceuticals.
It takes in-depth knowledge and experience to navigate the intricate regulatory environments of the US and the EU. Our team has extensive experience working with various health agencies like the FDA, EMA, and Health Canada. We understand the importance of building strong relationships with these authorities and can help navigate the complex regulatory environment to achieve your goals.
Here at Zenovel, we provide committed regulatory collaboration services to support the approval and success of your pharmaceutical products in these vital regions.
Experienced professionals with vast knowledge of FDA and EU regulations
Streamline process, Reduce time to market, Minimize delays
Mitigate risk, Enhance approval success rates
Acts as a local partner, Offer insights
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
Navigating the world of pharmaceuticals, medical devices, and biotechnology is never straightforward. With the diversity of regulatory compliance governs the Code of Federal Regulations (CFR) – a regulatory path that shapes companies’ efforts and implements how companies long for their products to be developed, manufactured, and marketed. For companies trying
The race to deliver life-saving therapies to patients is increasingly faster and more complex. Pharmaceutical and biotech companies are faced with a dizzying list of challenges — global clinical trials, continuously changing regulations, multiple complicated therapeutic areas, and pressure to innovate. This is where Contract Research Organizations (CRO) come in:
